|
1
|
Carcas LP: Gastric cancer review. J
Carcinog. 13:142014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Watson GL, Goff C and Shi P: Pohlmann:
Molecular profiling of gastric cancer. My Cancer Genome. Mar
16–2018.
|
|
3
|
Mihmanli M, Ilhan E, Idiz UO, Alemdar A
and Demir U: Recent developments and innovations in gastric cancer.
World J Gastroenterol. 22:4307–4320. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McFarlane M, Brettschneider J, Gelsthorpe
A, James S, Snead D, Gopalakrishnan K, Mehenna H, Jankowski J,
Arasaradnam R and Nwokolo C: An assessment of candidate genes to
assist prognosis in gastric cancer. J Gastrointest Oncol.
9:303–310. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yusefi AR, Bagheri Lankarani K, Bastani P,
Radinmanesh M and Kavosi Z: Risk factors for gastric cancer: A
systematic review. Asian Pac J Cancer Prev. 19:591–603.
2018.PubMed/NCBI
|
|
6
|
McDaniel LD, Conkrite KL, Chang X, Capasso
M, Vaksman Z, Oldridge DA, Zachariou A, Horn M, Diamond M, Hou C,
et al: Common variants upstream of MLF1 at 3q25 and within CPZ at
4p16 associated with neuroblastoma. PLoS Genet. 13:e10067872017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Perez Y, Menascu S, Cohen I, Kadir R,
Basha O, Shorer Z, Romi H, Meiri G, Rabinski T, Ofir R, et al:
RSRC1 mutation affects intellect and behaviour through aberrant
splicing and transcription, downregulating IGFBP3. Brain.
141:961–970. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cazalla D, Newton K and Caceres JF: A
novel SR-related protein is required for the second step of
Pre-mRNA splicing. Mol Cell Biol. 25:2969–2980. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Teplyuk NM, Uhlmann EJ, Gabriely G,
Volfovsky N, Wang Y, Teng J, Karmali P, Marcusson E, Peter M, Mohan
A, et al: Therapeutic potential of targeting microRNA-10b in
established intracranial glioblastoma: First steps toward the
clinic. EMBO Mol Med. 8:268–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pflueger D, Terry S, Sboner A, Habegger L,
Esgueva R, Lin PC, Svensson MA, Kitabayashi N, Moss BJ, MacDonald
TY, et al: Discovery of non-ETS gene fusions in human prostate
cancer using next-generation RNA sequencing. Genome Res. 21:56–67.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kurehara H, Ishiguro H, Kimura M, Mitsui
A, Ando T, Sugito N, Mori R, Takashima N, Ogawa R, Fujii Y and
Kuwabara Y: A novel gene, RSRC2, inhibits cell proliferation and
affects survival in esophageal cancer patients. Int J Oncol.
30:421–428. 2007.PubMed/NCBI
|
|
12
|
Wolf M, Korja M, Karhu R, Edgren H,
Kilpinen S, Ojala K, Mousses S, Kallioniemi A and Haapasalo H:
Array-based gene expression, CGH and tissue data defines a 12q24
gain in neuroblastic tumors with prognostic implication. BMC
Cancer. 10:1812010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hopkins BD, Hodakoski C, Barrows D, Mense
SM and Parsons RE: PTEN function: The long and the short of it.
Trends Biochem Sci. 39:183–190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yao H, Su S, Xia D, Wang M, Li Z, Chen W,
Ren L and Xu L: F-box and leucine-rich repeat protein 5 promotes
colon cancer progression by modulating PTEN/PI3K/AKT signaling
pathway. Biomed Pharmacother. 107:1712–1719. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Naderali E, Khaki AA, Rad JS, Ali-Hemmati
A, Rahmati M and Charoudeh HN: Regulation and modulation of PTEN
activity. Mol Biol Rep. 45:2869–2881. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu R, Zhao G, Yang Y, Jiang Z, Cai J,
Zhang Z and Hu H: Long noncoding RNA HOTAIRM1 inhibits cell
progression by regulating miR-17-5p/PTEN axis in gastric cancer. J
Cell Biochem. 120:4952–4965. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee YR, Chen M and Pandolfi PP: The
functions and regulation of the PTEN tumour suppressor: New modes
and prospects. Nat Rev Mol Cell Biol. 19:547–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang LL, Liu J, Lei S, Zhang J, Zhou W
and Yu HG: PTEN inhibits the invasion and metastasis of gastric
cancer via downregulation of FAK expression. Cell Signal.
26:1011–1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu W, Yang Z, Xie C, Zhu Y, Shu X, Zhang
Z, Li N, Chai N, Zhang S, Wu K, et al: PTEN lipid phosphatase
inactivation links the hippo and PI3K/Akt pathways to induce
gastric tumorigenesis. J Exp Clin Cancer Res. 37:1982018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ding K, Wu Z, Wang N, Wang X, Wang Y, Qian
P, Meng G and Tan S: MiR-26a performs converse roles in
proliferation and metastasis of different gastric cancer cells via
regulating of PTEN expression. Pathol Res Pract. 213:467–475. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L, Li W, Qiu W, Ren W, Li Q, Han B,
Zhou L, Cheng L, Zhang H and Ye Q: RSRC1 SUMOylation enhances
SUMOylation and inhibits transcriptional activity of estrogen
receptor β. FEBS Lett. 589:1476–1484. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang J, Liu W, Zhu J, Zhang J, Wang FH,
Liang JH, Zeng JH, Wang H, Xia H and He J: RSRC1 and CPZ gene
polymorphisms with neuroblastoma susceptibility in Chinese
children. Gene. 662:83–87. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Davidson L, Maccario H, Perera NM, Yang X,
Spinelli L, Tibarewal P, Glancy B, Gray A, Weijer CJ, Downes CP and
Leslie NR: Suppression of cellular proliferation and invasion by
the concerted lipid and protein phosphatase activities of PTEN.
Oncogene. 29:687–697. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ko BS, Chang TC, Chen CH, Liu CC, Kuo CC,
Hsu C, Shen YC, Shen TL, Golubovskaya VM, Chang CC, et al:
Bortezomib suppresses focal adhesion kinase expression via
interrupting nuclear factor-kappa B. Life Sci. 86:199–206. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X and Jiang X: PTEN: A default
gate-keeping tumor suppressor with a versatile tail. Cell Res.
18:807–816. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma J, Guo X, Zhang J, Wu D, Hu X, Li J,
Lan Q, Liu Y and Dong W: PTEN gene induces cell invasion and
migration via regulating AKT/GSK-3β/β-catenin signaling pathway in
human gastric cancer. Dig Dis Sci. 62:3415–3425. 2017. View Article : Google Scholar : PubMed/NCBI
|
